Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Catherine Perry
Professor, Medicine | Professor, Pathology | Member of the Graduate Faculty
Pathology and Lab Medicine
Full Page
Overview
Research
More
Collaboration
(9)
Denise Roe
Mutual work: 4 Proposals
Collaboration Details
Janko Nikolich
Mutual work: 1 Grant﹒1 Proposal
Collaboration Details
Chiu-Hsieh Hsu
Mutual work: 1 Proposal
Collaboration Details
Deepta Bhattacharya
Mutual work: 1 Grant﹒1 Proposal
Collaboration Details
Andrew Paek
Mutual work: 2 Proposals
Collaboration Details
Page 1 of 2
Previous page
Next page
Grants
(3)
ANCHOR- Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions (HSIL)
Active
·
2020
·
$0 / $3.9M
·
External
Co-Investigator (COI)
anal cancer prevention,
hiv patients,
topical treatment,
ablative treatment,
high-grade squamous intraepithelial lesions
University of Arizona COVID-19 Serology Testing
Active
·
2020
·
$250K / $3.5M
·
External
Key Personnel (KP)
covid-19,
serology,
university,
testing,
arizona
University of Arizona COVID-19 Serology Testing
Active
·
2020
·
$100K / $1M
·
External
Key Personnel (KP)
covid-19,
serology,
university,
testing,
arizona
Publications
(23)
Recent
SARS-CoV-2 Rapid Antigen Testing of Symptomatic and Asymptomatic Individuals on the University of Arizona Campus
2021
covid-19,
antigen testing,
symptomatic,
asymptomatic,
university campus
Detection, prevalence, and duration of humoral responses to SARS-CoV-2 under conditions of limited population exposure
2020
sars-cov-2,
humoral responses,
prevalence,
detection,
population exposure
Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity
2020
sars-cov-2,
serological assays,
humoral immunity,
surveillance,
communities
Sibling Donor-Derived Myeloid Sarcoma After Hematopoietic Stem Cell Transplant
2020
stem cell transplant,
myeloid sarcoma,
donor,
hematopoietic,
siblings
Phase I Study of the Investigational Aurora A Kinase Inhibitro Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma.
2018
cancer,
drug development,
clinical trial,
lymphoma,
targeted therapy
Continued Excellent Outcomes in Previously Untreated Patients With Follicular Lymphoma After Treatment With CHOP Plus Rituximab or CHOP Plus I-Tositumomab: Long-Term Follow-Uof Phase III Randomized Study SWOG-S0016
2018
follicular lymphoma,
chop plus rituximab,
long-term follow-up,
i-tositumomab
Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohort
2018
histological grading,
survival,
follicular lymphoma,
swog s0016,
impact
Subclonal mutations of TP53 are common in untreated follicular lymphoma and mutation status is predictive of PFS when CHOP is combined with 131-Iodine Tositumomab but not with Rituximab: An analysis of SWOG S0016
2018
lymphoma,
mutation,
treatment,
predictive factor,
chemotherapy
Co-targeting Aurora kinase with PD-L1 and PI3K abrogates immune checkpoint mediated proliferation in Peripheral B-cell Lymphoma: A novel theraeutic strategy.
2017
cancer immunotherapy,
cell proliferation,
lymphoma therapy,
targeted therapy,
kinase inhibition
Inhibition of polyploidy and senescence induces intrinsic apoptosis in double hit or double expresser DLBCL
2017
cancer,
apoptosis,
senescence,
polyploidy,
dlbcl
